Hememics Biotechnologies Inc.

About Hememics Biotechnologies Inc.

Hememics Biotechnologies, Inc. is a company focused on developing fast, accurate, and affordable graphene biosensors. Their mission is to transform diagnostics and detection across various industries through a low-cost, multiplexed biosensor platform that detects small molecule, molecular, and protein targets simultaneously.

Products & Services

HemBox™:A handheld device that provides quick, actionable results from a single sample.

HemChip:A biochip component of their platform for detecting various targets.

Specialties

Graphene biosensors Multiplexed biosensor platform Rapid detection for biodefense (biotoxins like ricin and botulinum) Agricultural testing (herbicides like dicamba and glyphosate) Drugs of abuse detection Healthcare diagnostics (protein and small molecule detection)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed 2 T: - FT: Seed 2	A: 2000000 MR: - FA: $2 million FAN: 2000000	D: 2023-05-25 FD: 2023-05-25	3 investors

Seed 2 Latest

2023-05-25

$2.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John L. Warden, Jr.

Co-Founder & CEO

H

Hoa T. Nguyen

Board member

D

David Ho

Founder, President & CSO

M

Mary E. Schmidt

Board member

M

Mary E. Schmidt, MD

Board member, President of Schmidt & Libby Health Advisory Group, Associate Professor of Clinical Medicine at VCU

H

Hao V. Nguyen

Board member

View 9 more team members with Pro

Unlock Full Team Directory

Recent News